About Bioventus

Innovations for Active Healing that Enhance the Body’s Ability to Heal

Bioventus is a global leader of innovations for active healing. Through a combination of internal product development, product/business acquisition, and distribution agreements, we will bring to market products which address a growing need for clinically effective, cost efficient, minimally invasive medical treatments, that engage and enhance the body’s natural healing processes.

Who We Are

Established in 2012, Bioventus Inc. (Nasdaq: BVS) is headquartered in Durham, NC. The company has more than 1,200 employees worldwide through its offices in Memphis, TN;  Valencia, CA;  Farmingdale, NY and Mississauga, Ontario, Canada; its international headquarters in Hoofddorp, The Netherlands and manufacturing location in Hod Hasharon, Israel. In 2022, products from Bioventus will help more than 600,000 people regain active lifestyles.


Established in 2012 in North Carolina


Employs more than 1,200 people worldwide


Works in more than 50 countries throughout the world

What We Do

Our mission is to partner with the health care community to deliver innovative medical devices and meet the evolving needs of patients, allowing them to resume and enjoy active lives. To this end, we develop and/or market clinically proven and cost-effective product offerings that are backed by clinical data. The products of Bioventus are known for their safety, innovation, and effectiveness.

The company focuses its medical product development around three segments: Pain Treatments, Restorative Therapies and Surgical Solutions.

The Pain Treatments and Joint Preservation products treat the chronic pain associated with osteoarthritis and peripheral nerve stimulation (PNS) products. These therapies relieve pain and help bring mobility back to the patient.

Restorative Therapies products for minimally invasive fracture treatments, wound treatment and rehabilitation. These therapies may also reduce the need for invasive procedures, leading to more cost-effective outcomes than previously possible.

Our Surgical Solutions advance the science and surgical performance of biologics with a comprehensive portfolio of clinically efficacious and cost effective bone graft substitutes and a suite of  minimally invasive therapeutic ultrasonic technologies optimized for hard and soft tissue removal.

Our offerings will expand to meet market demand to improve healing and contain healthcare costs.


Learn More About Our Products

Our Global Reach